ImmunityBio, Inc.
IBRX
$2.51
$0.031.21%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
9/17/2025
-
MarketBeat
10/14/2025
-
MarketBeat
10/6/2025
-
Ticker Report
10/4/2025
-
Simply Wall St
10/3/2025
-
MarketBeat
10/3/2025
-
Seeking Alpha - Long Ideas
10/3/2025
-
SeekingAlpha
10/1/2025
-
Yahoo! Finance: News
9/29/2025
-
Insider Monkey
9/29/2025
-
Insider Monkey
9/29/2025
-
ETF Channel
9/26/2025
-
MarketBeat
9/22/2025
-
Simply Wall St
9/20/2025
-
Insider Monkey
9/17/2025
-
Simply Wall St
9/17/2025
-
Stocktwits News Feed
9/16/2025
-
CNW Group - News Releases
9/16/2025
-
PR Newswire
9/15/2025
-
Yahoo! Finance: News
9/14/2025
-
Insider Monkey
9/14/2025
-
Simply Wall St
9/12/2025
-
MarketBeat
9/11/2025
-
MarketBeat
9/11/2025
-
SeekingAlpha
9/10/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, August 5, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
844 696 5235
Address
3530 John Hopkins Court
San Diego, CA 92121
San Diego, CA 92121
Country
Year Founded
--
Business Description
Sector
ImmunityBio, Inc., a commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases. Its platforms...
more